Related Experiment Videos

[Effects of diltiazem on rest and stress hemodynamics in coronary disease]

Zeitschrift Fur Kardiologie
|August 1, 1984
PubMed

Insights

Calcium channel blocker Diltiazem (D) did not negatively impact heart function in patients with coronary heart disease. Diltiazem reduced blood pressure and heart rate, likely decreasing myocardial oxygen consumption during stress.

Area of Science:

  • Cardiology
  • Pharmacology
  • Physiology

Context:

  • Assessing the acute hemodynamic effects of calcium antagonists is crucial for managing coronary heart disease (CHD).
  • Diltiazem is a commonly used calcium antagonist with known cardiovascular effects.
  • Understanding its impact during cardiac catheterization provides insights into its therapeutic potential.

Purpose:

  • To evaluate the acute hemodynamic effects of intravenous Diltiazem (0.3 mg/kg) in patients with coronary heart disease undergoing diagnostic cardiac catheterization.
  • To assess changes in ventricular performance, arterial pressure, and heart rate at rest and during ergometric stress before and after Diltiazem administration.

Summary:

  • Intravenous Diltiazem (0.3 mg/kg) administration resulted in a transient increase in left ventricular filling pressure, followed by significant decreases in systolic and mean arterial pressure.
  • Heart rate did not exhibit reflex increase and was significantly lower 15 minutes post-infusion. Stroke volume index showed a modest increase.
  • During ergometric stress, Diltiazem reduced left ventricular filling pressure and blunted the heart rate response, suggesting no significant negative inotropic effect and a probable decrease in myocardial oxygen consumption.

Impact:

  • Diltiazem, at the specified dose, appears safe for acute hemodynamic management in CHD patients undergoing stress testing.
  • The findings suggest Diltiazem may reduce myocardial oxygen demand by lowering systolic pressure and heart rate during exertion.
  • This study provides evidence supporting the use of Diltiazem in patients with CHD, highlighting its favorable hemodynamic profile under stress.

Related Concept Videos